CUAMC
DNA icon

China Universal Asset Management Company’s Ginkgo Bioworks DNA Stock Holding History

China Universal Asset Management Company’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-745
Closed -$71K – 445
2022
Q2 		$71K Hold
745
– – 0.03% 78
2022
Q1 		$120K Sell
745
-5,430
-88% -$1.06M 0.04% 72
2021
Q4 		$2.05M Buy
+6,175
New +$2.93M 0.49% 60

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

China Universal Asset Management Company's DNA Position: Q3 2022 in Review

China Universal Asset Management Company sold out of Ginkgo Bioworks (DNA) in Q3 2022, closing a stake of 745 shares — an estimated $71K sold.

China Universal Asset Management Company first reported a position in DNA in Q4 2021 and held it in 3 quarters. The position peaked at $2.05M in Q4 2021. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • China Universal Asset Management Company reported no remaining Ginkgo Bioworks position as of Q3 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 745 Ginkgo Bioworks shares in Q3 2022, an estimated $71K.
  • China Universal Asset Management Company first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 3 quarters.
  • China Universal Asset Management Company's Ginkgo Bioworks position peaked at $2.05M in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on China Universal Asset Management Company's 13F filing for Q3 2022, filed 21 Oct 2022.